Camlin Fine Sciences: 51% Share Surge Amid Anti-Dumping Duties on Chinese Vanillin

Key Pointers

Camlin Fine Sciences shares surged 51% in the past month as the US and EU imposed anti-dumping duties on Chinese vanillin imports.
EU's anti-dumping duty on Chinese vanillin is 131.1%, following similar US measures, significantly raising vanillin prices in key export markets.
Camlin's aroma exports business is expected to benefit over the next 3-4 quarters.
The company plans to ramp up vanillin capacity utilization from 45-50% to 100% in two years, lowering per-unit costs.

Revenue from the blends segment rose to ₹878 crore in FY25 (from ₹747 crore in FY24), and aroma ingredients jumped to ₹176 crore (from ₹35 crore).
Total revenue for FY25 grew 15% to ₹1,666.5 crore.
EBITDA margin remained stable at 12.5% in FY25; net debt reduced to ₹492 crore, improving the debt-to-equity ratio to 0.5.
Brokers raised valuation multiples, expecting further performance improvement as high-margin blends and vanillin prices rise.

Camlin's growth is driven by specialty chemicals for food, animal feed, fragrance, pharma, and industrial use.
Management targets 20% growth in blends over the next 2-3 years, with EBITDA margins expected to reach the high teens in some geographies.
The stock closed at ₹300 on BSE, up 182% year-on-year.

Anti-dumping duties on Chinese vanillin have created a strong tailwind for Camlin Fine Sciences, boosting both share price and business outlook.
Further upside depends on Camlin's ability to scale production, maintain margins, and deliver consistent financial performance.
Improved debt position and higher valuation multiples reflect growing investor confidence.
Investors should monitor sustainability of recent gains as market dynamics and competition evolve.

Camlin Fine Sciences is poised for growth, but long-term returns will depend on execution and global market trends.